New York, NY –  Vantage mHealthcare Inc., (OTCQB: VNTH) ("Vantage") or (the "Company") today announced that Vantage’s manufacturer expects to deliver 100 Health Sensors over the next month to hospitals and research facilities in the United States and New Zealand, advancing to the next phase of its research and development process, in order to prepare for human clinical trials.

New York, NY – Vantage mHealthcare, Inc. (OTCQB: VNTH) (“Vantage Health” or the “Company”) today announced that the corporate name has officially changed to Vantage mHealthcare, Inc. to better align the strategic direction of the Company within the growing and innovative mobile healthcare technology sector.

Redwood City, Calif.--(OTCQB: VNTH) - Vantage Health Inc. (VNTH) ("Vantage Health" or the "Company") today announces recent scientific updates and corporate developments.

Redwood City, CA – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health") or (the "Company") today announced that the Company has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. Theranostics laboratory was founded at the Cleveland Clinic in 2010 and works on subcontracted research, in collaboration with the Auckland Bioengineering Institute (ABI), in New Zealand, and with NASA (via NASA Grant NCC 9-58).

Redwood City, CA – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or (the “Company") today announced the appointment of Edward Rollins to its Board of Directors.

Redwood City, CA  – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health") or (the "Company") today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will also serve as President of the company.  Among other things, he will be involved in exploring possible applications of the company’s technology to narcotics detection.  Mr. Peters will replace departing board member Will Rees.

Redwood City, CA  – Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health") or (the "Company") today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board.  Dr. Steinhubl replaces interim chairman, Dr. Kevin Buckman who will remain with the company in an advisory capacity.

Redwood City, CA – Vantage Health Inc., (OTCQB: VNTH)  ("Vantage Health") or (the "Company") today announced the appointment of Tony van Bijleveld as an independent member of the Board of Directors of Vantage Health, Inc.